Search results for: 'vitro'

30 Oct 2024  |  Global  |  Market Research

Clinical Chemistry and Immunoassay Industry, Global, 2023?2028

Integrated and Scalable Core Lab Solutions Driving Transformational Growth

Infographics

×

This analysis examines the global clinical chemistry and immunoassay sector, accounting for the highest share in the in vitro diagnostics (IVD) market. This type of lab-based testing analyzes body fluids (usually blood, urine, or saliva) using integrated/standalone analyzers and a wide range of assays/panels, among other solutions and services to s...

A major challenge in drug discovery is the limited number of gene targets that can be targeted for the development of a drug molecule. Only close to 400 genes are proven targets for US FDA-approved drugs. 80% of human genes are unexplored as targets, and some are considered undruggable. The identification and the selection of novel drug targets (p...

30 Apr 2020  |  Asia Pacific  |  Market Outlook

COVID-19—Implications for the Healthcare Industry, 2020

Winning Strategies and Key Opportunities that are Evolving During this Disruption

Infographics

×

A team of futurists, analysts, and consultants from the Global Transformational Health Research Team at Frost & Sullivan have come together to render a comprehensive analysis to predict the future of healthcare with COVID-19 disruption in perspective. This study provides actionable predictions and growth opportunities for major healthcare segments ...

14 Mar 2022  |  North America  |  Market Outlook

Next-generation Diagnostics Outlook, 2022

Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth

Infographics

×

In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...

13 Aug 2020  |  Europe  |  Frost Radar

Frost Radar™: European Mass Spectrometer Market, 2020

A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

European mass spectrometer vendors are transforming their offerings from basic laboratory equipment into effective diagnostic equipment. The European Union’s expanded In Vitro Diagnostic Regulation (IVDR) for medical devices, set to take effect in May 2022, will have a dramatic effect on the industry. Manufacturers’ next-generation mass spectrome...

Assisted reproductive technology (ART) includes advanced fertility treatments and procedures, such as the manipulation of eggs, sperm, or embryos to increase the chances of a successful pregnancy. This study primarily examines the market for in vitro fertilization (IVF), a common ART procedure. It highlights innovations around the pre-implantation ...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, neuromodulation systems, and diagnostic solutions industry. The issue features advanced medical devices such as intelligent drug delivery system, immersive therapeuti...

02 Mar 2021  |  North America  |  Market Outlook

Developing Innovative ROI Streams and Patient-centric Virtual Care Approaches will Shape the Global Healthcare Industry, Outlook 2021

Digital Transformation Leads to New Growth Strategies for Stakeholders

Infographics

×

The global COVID-19 pandemic and other geo-political events left many businesses facing an unprecedented state of uncertainty. Healthcare companies across the care continuum remain grappling with these new challenges, of which the extent and longevity remain unknown. Spurred by the years events, healthcare delivery has accelerated its transformatio...